NRX Pharmaceuticals, Inc. (NRXP) Deferred State and Local Income Tax Expense (Benefit)

NRX Pharmaceuticals, Inc. Deferred State and Local Income Tax Expense (Benefit)

NRX Pharmaceuticals, Inc. (NRXP) reported Deferred State and Local Income Tax Expense (Benefit) of -$225.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-23.

Financial Statements › Expense Statement › Income Tax

us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit · last filed 2026-03-23

• NRX Pharmaceuticals, Inc. deferred state and local income tax expense (benefit) for the quarter ending 2017-12-31 was $0.00.
• NRX Pharmaceuticals, Inc. deferred state and local income tax expense (benefit) for fiscal 2025 was -$225.00K.
• NRX Pharmaceuticals, Inc. deferred state and local income tax expense (benefit) for fiscal 2024 was -$43.00K, a 103.01% decline from fiscal 2023.
• NRX Pharmaceuticals, Inc. deferred state and local income tax expense (benefit) for fiscal 2023 was $1.43M.
• NRX Pharmaceuticals, Inc. deferred state and local income tax expense (benefit) for fiscal 2022 was -$647.00K.